Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
47.63
+0.12 (0.25%)
At close: Jul 2, 2025, 4:00 PM
47.68
+0.05 (0.10%)
After-hours: Jul 2, 2025, 7:59 PM EDT
BMY Employees
Bristol-Myers Squibb Company had 34,100 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
34,100
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,396,950
Profits / Employee
$158,915
Market Cap
96.93B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
BMY News
- 1 day ago - Bristol-Myers Squibb: Strong Launch Portfolio Amid Market Reset - Seeking Alpha
- 3 days ago - Bristol-Myers Squibb: You Might Wish You Bought More Now (Upgrade) - Seeking Alpha
- 6 days ago - U.S. Food and Drug Administration Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb's Cell Therapy Labels - Business Wire
- 8 days ago - Cigna sues Bristol Myers over alleged monopoly for multiple myeloma drug Pomalyst - Reuters
- 8 days ago - 10 'Safer' Dividend Buys Of Barron's Better Bets Than T-Bills For June - Seeking Alpha
- 12 days ago - I'm Buying Dividend Giants At Huge Discounts - Seeking Alpha
- 15 days ago - Bristol Myers Squibb Announces Dividend - Business Wire
- 16 days ago - Bristol Myers Squibb Presents First Data from the Marginal Zone Lymphoma Cohort of the Transcend FL Trial Demonstrating Deep and Durable Responses with Breyanzi (lisocabtagene maraleucel) - Business Wire